Sansec Pharma Solutions Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 11 Months
- Last Filing with ROC 31 Mar 2020
- Revenue Growth 53.93%
- Profit Growth 53.46%
- Ebitda 46.78%
- Net Worth 131.21%
- Total Assets 112.05%
About Sansec Pharma Solutions
Sansec Pharma Solutions Private Limited (SPSPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 March 2018 (Six years and 11 months 1 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Nagendra Vallamkonda and Padmavathi Kanduri serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24304TG2018PTC122902
-
Company No.
122902
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Mar 2018
-
Date of AGM
31 Dec 2020
-
Date of Balance Sheet
31 Mar 2020
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Sansec Pharma Solutions?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nagendra Vallamkonda
|
Director | 12-Mar-2018 | Current |
|
Padmavathi Kanduri
|
Director | 12-Mar-2018 | Current |
Financial Performance of Sansec Pharma Solutions.
Sansec Pharma Solutions Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 53.93% increase. The company also saw a substantial improvement in profitability, with a 53.46% increase in profit. The company's net worth Soared by an impressive increase of 131.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sansec Pharma Solutions?
In 2020, Sansec Pharma Solutions had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Skandanana Pharma Private LimitedNagendra Vallamkonda is a mutual person
-
Skandana Life Sciences LlpNagendra Vallamkonda is a mutual person
-
Skandanan Infra Projects Private Limited
Nagendra Vallamkonda is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sansec Pharma Solutions?
Unlock and access historical data on people associated with Sansec Pharma Solutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sansec Pharma Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sansec Pharma Solutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
